MRK News Thursday, September 24, 2026 0.00 Neutral

Merck Says Investigational Diabetes-Related Blindness Drug at Par With Roche’s Medicine

AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed